Bun 1.3 revolutionizes full-stack JavaScript development with unified database APIs and zero-config frontend setup.
Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart cafraglutide; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback